An Open-Label Study of DCCR Tablet in Patients With PWS
NCT04086810 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2021-08-03
Summary
The primary objective of this study is to monitor the long-term safety of DCCR in PWS patients.
Conditions
Interventions
- DRUG
-
DCCR
Once daily oral administration
Sponsors & Collaborators
-
Soleno Therapeutics, Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 4 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-31
- Primary Completion
- 2019-10-31
- Completion
- 2019-10-31
- FDA Drug
- Yes
More Related Trials
-
A Study of GLWL-01 in Patients With Prader-Willi Syndrome
NCT03274856 ·Status: COMPLETED ·Phase: PHASE2
-
Personalized Antisense Oligonucleotide Therapy for A Single Participant With ATN1 Gene Mutation
NCT06706388 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
NCT01894958 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
NCT02124083 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) Disease
NCT03687476 ·Status: WITHDRAWN ·Phase: PHASE2
-
Global Open-Label Extension Study of Del-desiran for the Treatment of DM1
NCT07008469 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age
NCT02484703 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)
NCT01794000 ·Status: TERMINATED ·Phase: PHASE3
-
PWS Outcomes Assessment Study
NCT04102839 ·Status: COMPLETED
-
Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease
NCT00004293 ·Status: UNKNOWN ·Phase: PHASE2
-
A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)
NCT07240896 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study of RG1662 in Individuals With Down Syndrome
NCT01436955 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized Controlled Study of Donepezil in Fragile X Syndrome
NCT01120626 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down Syndrome
NCT00294593 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of CDX 6114 in PKU Patients
NCT04256655 ·Status: WITHDRAWN ·Phase: PHASE1
-
Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1
NCT03879655 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Adrenoleukodystrophy
NCT03196765 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy Subjects
NCT05388903 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
NCT03047980 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsan™ in Patients With Cockayne Syndrome
NCT01142154 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome.
NCT07266324 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
NCT02823145 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of CSTI-500 in Patients With Prader-Willi Syndrome
NCT07348601 ·Status: RECRUITING ·Phase: PHASE2
-
Sirolimus for Cowden Syndrome With Colon Polyposis
NCT04094675 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Pitolisant in Participants With Prader-Willi Syndrome
NCT07219485 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3